AIM

AIM ImmunoTech Inc
AMEX

实时行情|Nasdaq Last Sale

2.570
-0.100
-3.75%
盘后: 2.570 0 0.00% 19:58 07/10 EDT
开盘
2.630
昨收
2.670
最高
2.650
最低
2.550
成交量
275.91万
成交额
--
52周最高
7.11
52周最低
0.3810
市值
8,384.41万
市盈率(TTM)
-1.0070
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AIM价格均价为6.17,最高价位7.00,最低价为5.00。

EPS

AIM 新闻

更多
AIM ImmunoTech teams up with Roswell Park for combo trial in COVID-19 patients with cancer
Seeking Alpha - Article · 2天前
Peacock licenses ViacomCBS programs for streaming
Seeking Alpha - Article · 07/01 15:05
Bernstein upgrades Comcast and urges spin-out of NBCUniversal, Sky
Seeking Alpha - Article · 07/01 13:25
What to watch today: Dow cut losses after best quarter in over three decades
Dow futures erase losses and turn positive Wednesday on positive results from a coronavirus vaccine trial.
CNBC.com · 07/01 13:03
Stocks making the biggest moves in the premarket: Macy's, United, FedEx, Boeing, Facebook & more
The stocks making the biggest moves in premarket trading include Macy's, United, FedEx, Boeing, Facebook, and more.
CNBC.com · 07/01 11:59
Google raises price of YouTube TV, its cable-like bundle, to $65 a month
The latest bump shows streaming services struggling to compete with cable prices despite being touted as a solution for cable-cutting.
CNBC.com · 06/30 17:31
AIM ImmunoTech Issues Press Release Announces the Company was Added to the Russell 2000 Index
Benzinga · 06/29 10:56
INO, DVAX among premarket gainers
Seeking Alpha - Article · 06/26 12:21

所属板块

生物技术和医学研究
-0.39%
制药与医学研究
-0.32%

热门股票

代码
价格
涨跌幅

AIM 简况

AIM ImmunoTech Inc., formerly Hemispherx Biopharma, Inc., is a specialty pharmaceutical company. The Company is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company's segment is engaged in research and development activities related to Ampligen and other drugs under development, and sales and marketing of Alferon. The Company's products include Alferon N Injection and Ampligen. Alferon N Injection is approved for the use in intralesional treatment of refractory or recurring external genital warts in patients of over 18 years of age. Ampligen is a drug undergoing clinical development for the treatment of Chronic Fatigue Syndrome (CFS). Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) is a low-dose, oral liquid formulation of natural alpha interferon. Alferon LDO is a liquid natural interferon for oral administration.
展开

微牛提供AIM ImmunoTech Inc(AMEX-AIM)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AIM股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易AIM股票基本功能。